Descovy 200-25MG 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FW9HR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,430
Award facts
- Contract value 100% obligated
- $14,430.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for DESCOVY 200-25MG tablets (30-count) on December 19, 2025, valued at $14,430.02 under firm fixed pricing. This non-competitive delivery order is scheduled for completion by January 16, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, is positioned as a child contract under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, which carries a $999.999 billion ceiling and extends through December 2026.
The delivery order represents a continuation of AmerisourceBergen's extensive role in supplying pharmaceutical products to the Department of Defense and military healthcare systems. As a primary vendor through its DLA IDC, the company routinely fulfills orders for brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains. DESCOVY is an antiretroviral medication used for HIV prevention and treatment, aligning with the Defense Health Agency's medical supply requirements for military personnel and beneficiaries. This award reflects AmerisourceBergen's established capability to meet federal healthcare procurement needs through competitive contracting mechanisms and its designation as a preferred pharmaceutical supplier within the DLA's global supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DR26FW9HR?
SPE2DR26FW9HR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 19, 2025.
How much is contract SPE2DR26FW9HR worth?
The government has obligated $14,430 on SPE2DR26FW9HR.
Is contract SPE2DR26FW9HR an order under another contract?
Yes. SPE2DR26FW9HR is a delivery order under SPE2DR25D7062, an indefinite delivery contract.
Was contract SPE2DR26FW9HR competed?
The extent of competition for SPE2DR26FW9HR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award